Dasiglucagon

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Dasiglucagon
DrugBank Accession Number
DB15226
Background

Dasiglucagon is under investigation in clinical trial NCT03735225 (Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration).

Type
Biotech
Groups
Approved, Investigational
Synonyms
  • Dasiglucagon

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
ZegalogueInjection, solution0.6 mg/0.6mLSubcutaneousZealand Pharma A/S2021-04-05Not applicableUS flag
ZegalogueInjection, solution0.6 mg/0.6mLSubcutaneousZealand Pharma A/S2021-04-05Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
AD4J2O47FQ
CAS number
1544300-84-6

References

General References
Not Available
RxNav
2535233

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentCongenital Hyperinsulinism1
3CompletedTreatmentHypoglycemia1
3CompletedTreatmentHypoglycemia / Type 1 Diabetes Mellitus4
3Enrolling by InvitationTreatmentCongenital Hyperinsulinism1
2CompletedTreatmentHyperinsulinemic Hypoglycemia / Postprandial Hypoglycemia1
2CompletedTreatmentHypoglycemia / Type 1 Diabetes Mellitus1
2CompletedTreatmentType 1 Diabetes Mellitus2
2Not Yet RecruitingTreatmentGlucose Metabolism Disorders / Hypoglycemia1
2Not Yet RecruitingTreatmentHyperinsulinemic Hypoglycemia / Postprandial Hypoglycemia1
2Not Yet RecruitingTreatmentHypoglycemia / Type 1 Diabetes Mellitus1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionSubcutaneous0.6 mg/0.6mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on May 20, 2019 15:01 / Updated on May 05, 2021 23:20